Zoetis Inc.ZTS

$78.71+1.45 (+1.88%)
NYSEHealthcare24:00 UTC

Company snapshot

Market Cap
$33B
Large-cap
+39%
2016 — today
10-Year Price
+64%
2016 — today
52-Week Range
$74.22$159.19
Current $78.71· 5%

Zoetis researches, develops, and manufactures veterinary pharmaceuticals, vaccines, and diagnostic tools for livestock (cattle, swine, poultry, fish, sheep) and companion animals (dogs, cats, horses). Its portfolio includes anti-infectives, parasiticides, pain management, oncology, and dermatological solutions. Beyond therapeutics, the company provides diagnostic systems, genetic testing, and precision animal health technology. Products reach veterinarians and producers via direct sales and distributors.

Valuation in context

P/E ratio
13.1
Near historic low
Near historic low — last 10 years
P/B ratio
10.3
Near historic low
Near historic low — last 10 years
EV / EBITDA
10.1
Near historic low
Near historic low — last 10 years
Dividend Yield
2.6%
Near historic high
Near historic highs — last 10 years
PEG ratio
1.3
Historically cheap
Historically cheap relative to the last 10 years
FCF Yield
6.4%
Near historic high
Near historic highs — last 10 years
Free · No credit card needed

Get alerted when ZTS is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.